In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN and JAKi. Some measures had greater improvement in JAKi group. Some patients can benefit from TNF cycling. Pappas D CorEvitas Abs1588 t.co/cHW5tm97kx #ACR22 @RheumNow
Outcomes of Etanercept and Janus Kinase Inhibitor Treatment After First-line Use of Adalimumab in Patients with Rheumatoid Arthritis - ACR Meeting Abstracts
